Literature DB >> 22520484

[Potentialisation of hyperkalemia effects by cinacalcet-induced hypocalcemia on dialysis].

François Simon1, Quentin Bertrand, Yves Pirson, Bruno Flamion, Guy Loute.   

Abstract

We report on two patients on chronic hemodialysis, who presented with typical symptoms of hyperkalemia (lower limb paresia and characteristic electrocardiogram [ECG]) for an only mildly increased kalemia (6.1 and 6.2 mEq/L), values that are frequently seen in asymptomatic patients on chronic hemodialysis. Their common denominator was a concomitant hypocalcemia (7.5 et 6.4mg/dL) induced by cinacalcet treatment. Hypocalcemia has very likely precipitated the occurrence of clinical and electrocardiological manifestations of hyperkalemia. This observation is in agreement with previous publications showing that, in other clinical situations than the use of cinacalcet, hypocalcemia potentiates the effect of hyperkalemia on muscle membrane. Nephrologists should be aware of this complication and pay most attention in their patients on chronic dialysis with a calcemia less than 8mg/dL induced by cinacalcet treatment.
Copyright © 2012 Association Société de néphrologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22520484     DOI: 10.1016/j.nephro.2012.03.003

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  1 in total

1.  Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes.

Authors:  Karly S Louie; Clement Erhard; David C Wheeler; Peter Stenvinkel; Bruno Fouqueray; Jürgen Floege
Journal:  J Nephrol       Date:  2019-12-17       Impact factor: 3.902

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.